William Demant and GN on intensified US competition: Monitoring the situation but see no threat
Danish hearing device groups William Demant and GN Hearing retain their composure after news from the rival Bose resulted in nosediving share prices. However, the companies monitor the situation very closely. Analyst calls the stock market's reaction "extremely exaggerated."
Danish hearing aid group William Demant has gotten food for thought after US-based company Bose launched a new hearing device and last week received FDA's approval.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
